» Articles » PMID: 37289362

Humoral Immunity Against Aspergillus Fumigatus

Overview
Journal Mycopathologia
Date 2023 Jun 8
PMID 37289362
Authors
Affiliations
Soon will be listed here.
Abstract

Aspergillus fumigatus is one the most ubiquitous airborne opportunistic human fungal pathogens. Understanding its interaction with host immune system, composed of cellular and humoral arm, is essential to explain the pathobiology of aspergillosis disease spectrum. While cellular immunity has been well studied, humoral immunity has been poorly acknowledge, although it plays a crucial role in bridging the fungus and immune cells. In this review, we have summarized available data on major players of humoral immunity against A. fumigatus and discussed how they may help to identify at-risk individuals, be used as diagnostic tools or promote alternative therapeutic strategies. Remaining challenges are highlighted and leads are given to guide future research to better grasp the complexity of humoral immune interaction with A. fumigatus.

Citing Articles

IL-17 in plasma and bronchoalveolar lavage fluid in non-neutropenic patients with invasive pulmonary aspergillosis.

He Q, Cao J, Zhang M, Feng C Front Cell Infect Microbiol. 2024; 14:1402888.

PMID: 39176263 PMC: 11339031. DOI: 10.3389/fcimb.2024.1402888.


Proteome and Dihydrorhodamine Profiling of Bronchoalveolar Lavage in Patients with Chronic Pulmonary Aspergillosis.

Assing K, Laursen C, Campbell A, Beck H, Davidsen J J Fungi (Basel). 2024; 10(5).

PMID: 38786669 PMC: 11122433. DOI: 10.3390/jof10050314.


Diagnosis of Chronic Pulmonary Aspergillosis: Clinical, Radiological or Laboratory?.

Barac A, Vujovic A, Drazic A, Stevanovic G, Paglietti B, Lukic K J Fungi (Basel). 2023; 9(11).

PMID: 37998889 PMC: 10672318. DOI: 10.3390/jof9111084.

References
1.
Donnelly J, Chen S, Kauffman C, Steinbach W, Baddley J, Verweij P . Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2019; 71(6):1367-1376. PMC: 7486838. DOI: 10.1093/cid/ciz1008. View

2.
Alanio A, Delliere S, Fodil S, Bretagne S, Megarbane B . Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med. 2020; 8(6):e48-e49. PMC: 7239617. DOI: 10.1016/S2213-2600(20)30237-X. View

3.
Denning D, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S . Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2015; 47(1):45-68. DOI: 10.1183/13993003.00583-2015. View

4.
Camara B, Reymond E, Saint-Raymond C, Roth H, Brenier-Pinchart M, Pinel C . Characteristics and outcomes of chronic pulmonary aspergillosis: a retrospective analysis of a tertiary hospital registry. Clin Respir J. 2014; 9(1):65-73. DOI: 10.1111/crj.12105. View

5.
Park S, Mehrad B . Innate immunity to Aspergillus species. Clin Microbiol Rev. 2009; 22(4):535-51. PMC: 2772361. DOI: 10.1128/CMR.00014-09. View